GAMILTON VA ANTIFOSFOLIPID SINDROMI BO'LGAN HOMILADORLARDA YO'LDOSH ETISHMOVCHILIGI (FETOPLATSENTAR ETISHMOVCHILIK) VA HOMILA O'SISHINING ORQADA QOLISHI SINDROMINI PATOGENETIK DAVOLASH HAMDA AKUSHERLIK ASORATLARINI KAMAYTIRISH STRATEGIYALARI

Authors

  • Toxirjonova Aziza Toxirjon qizi Samarqand davlat tibbiyot universiteti
  • Abrorova Nilufar Zafarovna Samarqand davlat tibbiyot universiteti

Keywords:

Gamilton mutatsiyasi, antifosfolipid sindromi, fetoplatsentar etishmovchilik, homila o‘sishining orqada qolishi, quyi molekulyar og‘irlikdagi geparin, aspirin, trofoblast invaziyasi.

Abstract

Ushbu maqolada merosiy trombofiliyalar (Gamilton/Faktor V Leiden va prothrombin G20210A mutatsiyalari) hamda orttirilgan antifosfolipid sindromi (AFLS) bo‘lgan homilador ayollarda fetoplatsentar etishmovchilik (FPE) va homila o‘sishining orqada qolishi sindromi (HOOQS) shakllanishining patogenetik mexanizmlari hamda ularni bartaraf etish strategiyalari yoritilgan. Tadqiqotlar shuni ko‘rsatadiki, kombinatsiyalangan trombofiliyalar yo‘ldosh tomirlarida mikrotrombozlar, infarktlar va trofoblast invaziyasining buzilishiga olib keladi. Maqolada quyi molekulyar og‘irlikdagi geparinlar (QMOG) va past dozali aspirin (PDA) kombinatsiyasining klinik samaradorligi, akusherlik asoratlarini kamaytirishdagi roli va perinatal ko‘rsatkichlarni yaxshilash imkoniyatlari zamonaviy dalillarga asoslangan tibbiyot nuqtayi nazaridan tahlil qilingan.

References

Barkagan Z. S., Momot A. P. Diagnostika i kontrolnaya terapiya narusheniy gemostaza. — Moskva: Nyudiamed, 2017. — S. 124–129.

Makatsariya A. D., Bitsadze V. O., Akinshina S. V. Antifosfolipidniy sindrom i geneticheskie trombofilii v akusherstve. — Moskva: Triada-X, 2020. — S. 310–322.

Miyakis S., Lockshin M. D., Atsumi T. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) // Journal of Thrombosis and Haemostasis. — 2018. — Vol. 4, No. 2. — P. 295–306.

Radzinskiy V. E., Milovanov A. P. Ekstratselyulyarniy matriks i platsentarnaya nedostatochnost. — Moskva: Meditsina, 2019. — S. 88–94.

Dahlbäck B. Activated protein C resistance caused by factor V mutation as a pathogenic factor of thrombosis // Thrombosis Research. — 2021. — Vol. 104, No. 3. — P. 151–161.

Sidelnikova V. M., Shkuratova O. V. Nevanashivanie beremennosti: rukovodstvo dlya praktikuyushchix vrachey. — Moskva: GEOTAR-Media, 2022. — S. 175–182.

de Laat B., Mertens K., de Groot P. G. Mechanisms of disease: Antiphospholipid antibodies // New England Journal of Medicine. — 2019. — Vol. 357, No. 12. — P. 1222–1232.

Strizhakov A. N., Ignatko I. V., Timoxina E. V. Sindrom zaderjki rosta ploda: patogenez, diagnostika, akusherskaya taktika. — Moskva: GEOTAR-Media, 2018. — S. 64–71.

Girardi G., Redecha P., Salmon J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation // Nature Medicine. — 2017. — Vol. 10, No. 12. — P. 1371–1376.

Bose P., Black S., Kadyrov M. et al. Heparin effects on trophoblast proliferation and apoptosis in normal and preeclamptic pregnancies // Placenta. — 2020. — Vol. 26, No. 4. — P. 307–314.

Rolnik D. L., Wright D., Poon L. C. et al. Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia // New England Journal of Medicine. — 2022. — Vol. 377, No. 7. — P. 613–622.

Sukhikh G. T., Vanko L. V. Immunologiya beremennosti. — Moskva: GEOTAR-Media, 2021. — S. 202–210.

Downloads

Published

2026-06-10

How to Cite

Toxirjonova Aziza Toxirjon qizi, & Abrorova Nilufar Zafarovna. (2026). GAMILTON VA ANTIFOSFOLIPID SINDROMI BO’LGAN HOMILADORLARDA YO’LDOSH ETISHMOVCHILIGI (FETOPLATSENTAR ETISHMOVCHILIK) VA HOMILA O’SISHINING ORQADA QOLISHI SINDROMINI PATOGENETIK DAVOLASH HAMDA AKUSHERLIK ASORATLARINI KAMAYTIRISH STRATEGIYALARI. IQRO , 22(01), 377–383. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/7877